Gene SLC22A18 capable of influencing fat metabolism and growth and development of children

A technology for abnormal growth and development and lipid metabolism, which is used in the determination/inspection of microorganisms, biological testing, biological material analysis, etc.

Active Publication Date: 2019-03-29
上海鸿准生物医药科技有限公司
View PDF4 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, the main clinical response and treatment measures include fasting, drugs, exercise and surgery. However, because children are in the growth and development period, the specific stage of life determines that children under the age of 16 cannot undergo fasting, drugs, strenuous exercise and surgery. Surgery

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Gene SLC22A18 capable of influencing fat metabolism and growth and development of children
  • Gene SLC22A18 capable of influencing fat metabolism and growth and development of children
  • Gene SLC22A18 capable of influencing fat metabolism and growth and development of children

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0117] Detection of SLC22A18 whole blood mRNA expression

[0118] In the experimental scheme of the present invention, a phenomenon of clinical symptoms was first discovered: dwarfism patients were thin and small in childhood, and their BMI was low, and free fatty acids were found to be higher than the normal range in blood lipid testing; obesity symptoms appeared in middle age, accompanied by severe fatty liver.

[0119] This example is to detect the mRNA of short stature patients with low BMI and normal BMI controls in childhood, and divide them into two groups: normal control group and thin group, and normal control group and thin patient's family for comparison.

[0120] In molecular experiments, use Beijing Biotech Blood (liquid sample) Total RNA Rapid Extraction Kit (Cat: RP4002) to extract whole blood RNA, take 1ug RNA for a reverse transcription, reverse transcription using Takara's PrimeScript TM RT Reagent kit kit (Cat#RR037A), the cDNA obtained using Takara's SYBR ...

Embodiment 2

[0125] Immunofluorescence detection of SLC22A18+ positive cells

[0126] Peripheral blood cells were detected and divided into normal control group and dwarfism group, as well as normal control group and dwarfism patient family for comparison.

[0127] In the immunofluorescence test, first use specific antibodies to classify and mark blood cells: CD19+ to mark B cells, CD11b+ to mark monocytes and macrophages, and CD3+ to mark T cells; after classification, mark SLC22A18+ cells respectively to detect their positive rate. Abcam antibodies were used for all antibodies. Fluorescence detection by flow cytometry.

[0128] The detection results showed that SLC22A18 was abundantly expressed on B cells in whole blood ( image 3 ); T cell expression is very low ( Figure 4 ); the expression in mononuclear macrophages decreased significantly ( Figure 5 ).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a gene SLC22A18 capable of influencing fat metabolism and growth and development of children, and particularly, provides applications of the gene SLC22A18, an mRNA, a cDNA, ora protein or a detection reagent thereof, as a marker for detecting abnormal lipid metabolism and/or to prepare a diagnosis reagent or a kit used for detecting the abnormal lipid metabolism; herein,the gene SLC22A18 has close relationship with dwarfism, thin and small physique, and childhood obesity, so that the gene can serve as a biomarker for abnormal development and abnormal metabolism. Theinvention provides a new potential clinical treatment target for treating childhood obesity or dwarfism.

Description

technical field [0001] The present invention relates to the field of genetics, more specifically relates to the gene SLC22A18 affecting fat metabolism and growth and development of children. Background technique [0002] The growth and development of children has always been one of the most important concerns of the society in the field of health. According to statistics in 2013, Shanghai, Beijing and other developed regions have reached an obesity rate of 21%, that is, one out of every five children is obese. Metabolic abnormalities in children are likely to cause endocrine abnormalities, and the most common clinical manifestations include thyroid disease, precocious puberty, short stature, and obesity metabolic syndrome. We mainly focus on abnormal growth and development in children related to abnormal lipid metabolism, including short (thin) stature and obesity. [0003] The etiology of short (thin) small syndrome is complex and diverse, and the etiological composition ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C12Q1/6883G01N33/68
CPCG01N33/6893C12Q1/6883G01N2800/04G01N2800/046G01N2800/048G01N2800/044G01N2800/085C12Q2600/158
Inventor 乔荆
Owner 上海鸿准生物医药科技有限公司
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap